Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share (JANX)

Historical Holders from Q2 2021 to Q1 2025

Symbol
JANX on Nasdaq
CUSIP
47103J105
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
60.2M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
64.1M
Holdings value
$3.43B
% of all portfolios
0.01%
Grand Portfolio weight change
+0.002%
Number of holders
213
Number of buys
142
Number of sells
-63
Average Value change %
+0%
Average buys %
+0.005%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share (JANX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 19.9% $323M 12M RA Capital Management, L.P. Mar 6, 2025
JANUS HENDERSON GROUP PLC 6.1% $96.2M 3.56M JANUS HENDERSON GROUP PLC Dec 31, 2024
Paradigm Biocapital Advisors LP 6% $94.9M 3.52M Paradigm BioCapital Advisors LP Dec 31, 2024
Adage Capital Management, L.P. 5.31% $82.7M 3.06M Adage Capital Management, L.P. Dec 31, 2024

Institutional Holders of Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share (JANX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 93.3K $2.52M +$755K $27.00 12
2024 Q4 64.1M $3.43B +$1B $53.54 213
2024 Q3 45.6M $2.07B +$42.3M $45.43 159
2024 Q2 44.7M $1.87B +$108M $41.89 152
2024 Q1 42.3M $1.59B +$332M $37.65 118
2023 Q4 33.5M $360M -$17.7M $10.73 64
2023 Q3 35.1M $354M +$43.9M $10.08 57
2023 Q2 30.5M $362M -$1.13M $11.87 54
2023 Q1 30.5M $370M +$18.6M $12.10 48
2022 Q4 29M $381M -$7.76M $13.17 48
2022 Q3 29.5M $400M +$8.92M $13.54 44
2022 Q2 28.9M $352M +$6.49M $12.21 39
2022 Q1 28.3M $407M +$10.9M $14.34 45
2021 Q4 27.5M $541M +$19.1M $19.73 45
2021 Q3 26.5M $571M +$36.9M $21.63 45
2021 Q2 24.7M $614M +$614M $24.95 29